메뉴 건너뛰기
Journal of the American College of Cardiology
Volumn 60, Issue 12, 2012, Pages 1119-1120
Reply
Author keywords

[No Author keywords available]
Indexed keywords

APIXABAN; DABIGATRAN; ENOXAPARIN; HEPARIN; RIVAROXABAN; WARFARIN;
EID: 84866140099     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.04.052     Document Type: Letter
Times cited : (1)
References (6)
  • 1
    • 84858709300 scopus 로고    scopus 로고
    • Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: Results from a multicenter prospective registry
    • D. Lakkireddy, Y.M. Reddy, L. Di Biase Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry J Am Coll Cardiol 59 2012 1168 1174
    • (2012) J Am Coll Cardiol , vol.59 , pp. 1168-1174
    • Lakkireddy, D.1    Reddy, Y.M.2    Di Biase, L.3
  • 2
    • 84855225857 scopus 로고    scopus 로고
    • Boehringer Ingelheim Pharmaceuticals Accessed March 28, 2012
    • Boehringer Ingelheim Pharmaceuticals Advisory Committee Briefing Document http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/UCM226009.pdf Accessed March 28, 2012
    • Advisory Committee Briefing Document
  • 3
    • 17644400166 scopus 로고    scopus 로고
    • Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement
    • DOI 10.1177/0091270005274550
    • J. Stangier, B.I. Eriksson, O.E. Dahl Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement J Clin Pharmacol 45 2005 555 563 (Pubitemid 40562946)
    • (2005) Journal of Clinical Pharmacology , vol.45 , Issue.5 , pp. 555-563
    • Stangier, J.1    Eriksson, B.I.2    Dahl, O.E.3    Ahnfelt, L.4    Nehmiz, G.5    Stahle, H.6    Rathgen, K.7    Svard, R.8
  • 4
    • 84857154488 scopus 로고    scopus 로고
    • New oral antithrombotics: Focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders
    • O.E. Dahl New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders Vasc Health Risk Manag 8 2012 45 57
    • (2012) Vasc Health Risk Manag , vol.8 , pp. 45-57
    • Dahl, O.E.1
  • 5
    • 77953809216 scopus 로고    scopus 로고
    • Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: The impact of periprocedural therapeutic international normalized ratio
    • L. Di Biase, J.D. Burkhardt, P. Mohanty et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio Circulation 121 2010 2550 2556
    • (2010) Circulation , vol.121 , pp. 2550-2556
    • Di Biase, L.1    Burkhardt, J.D.2    Mohanty, P.3
  • 6
    • 84862240330 scopus 로고    scopus 로고
    • Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: Evidence from a meta-analysis
    • P. Santangeli, L. Di Biase, R. Horton et al. Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis Circ Arrhythm Electrophysiol 5 2012 302 311
    • (2012) Circ Arrhythm Electrophysiol , vol.5 , pp. 302-311
    • Santangeli, P.1    Di Biase, L.2    Horton, R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.